{
	"symbol": "MDNA",
	"name": "Medicenna Therapeutics Corp.",
	"price": 1.57,
	"priceChange": 0.08,
	"percentChange": 5.369128,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 34606,
	"openPrice": 1.53,
	"dayHigh": 1.57,
	"dayLow": 1.49,
	"MarketCap": 122707903,
	"MarketCapAllClasses": 122707908,
	"peRatio": "",
	"prevClose": 1.49,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 1.189284,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients.",
	"fulldescription": "Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients.",
	"website": "http://www.medicenna.com",
	"email": "ir@medicenna.com",
	"phoneNumber": "416-648-5555",
	"fullAddress": "2 Bloor Street W,7th Floor, Toronto, ON, CA",
	"employees": "16",
	"shareOutStanding": 78157900,
	"totalDebtToEquity": 0,
	"totalSharesOutStanding": 78157903,
	"sharesESCROW": 14682859,
	"vwap": 1.54297376,
	"dividendPayDate": null,
	"weeks52high": 2.98,
	"weeks52low": 0.38,
	"alpha": 0.051339,
	"averageVolume10D": 158396,
	"averageVolume20D": 119202,
	"averageVolume30D": 99230,
	"averageVolume50D": 84328,
	"priceToBook": 5.36,
	"priceToCashFlow": -13.2,
	"returnOnEquity": -105.43,
	"returnOnAssets": -75.44,
	"day21MovingAvg": 2.02,
	"day50MovingAvg": 2.0672,
	"day200MovingAvg": 1.960225,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 1.57,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}